Navigating the global supply of starting materials for cell-based therapies

Elena Meurer & Jennifer Sales

The use of biological starting materials in the development of allogeneic cell-based therapies poses several challenges, whether due to availability of appropriate donors, complicated global logistics, or lack of global regulatory harmonisation around technical testing requirements

Start a conversation today